am h t s A g in m a r f e R l a ic n li C o t e c n e from Evid Practice REGISTRATION LINK:
Date: Tuesday, 18th May 2021
https://cvent.me/K0edmQ
Time: 5:30pm - 7:45pm
Venue: Novotel Rotorua Lake End, Tutanekai Street, Rotorua 3010
Your representative’s details: Alison Duncan T: 027 501 1153
Noelene Rapana Community Respiratory Nurse Specialist Noelene Rapana (Ngāti Hurungaterangi, Ngāti Tūwharetoa, Ngāti- Porou) has been a Registered Nurse for the past 27 years specializing in Respiratory for the past eight. Noelene is currently the Project Manager for the Whaimua Respiratory Programme lead by Korowai Aroha Health Centre, sits on the PHARMAC Respiratory Inhalers Advisory Committee and delivers best practice guidelines for the Asthma & Respiratory Foundation. Noelene has an innate drive to support those affected by inequity and is passionate about working holistically.
Agenda: 5:30pm Canapes & Drinks 6:30pm Open & Welcome Chairperson; Noelene Rapana 6:45pm PRESENTATION: Reframing Asthma - from Evidence to Clinical Practice; Professor Beasley 7:30pm Q&A 7:45pm Meeting Close
Professor Richard Beasley CNZM, DSC(OTAGO), DM(SOUTHAMPTON), MBCHB, FRCP(LONDON), FRACP, FAAAAI, FFOM(HON), FAPSR(NEW ZEALAND), FERS, FRSNZ: Professor Richard Beasley is a physician at Wellington Regional Hospital, Director of the Medical Research Institute of New Zealand, and Professor of Medicine at Victoria University of Wellington. He is an Adjunct Professor at the University of Otago and Visiting Professor, University of Southampton, United Kingdom. He is the Chair of the Asthma and Respiratory Foundation NZ Adolescent and Adult Guidelines Working Group, and a member of the ARFNZ Scientific Advisory Board, and was previously the deputy chair of the health research council of NZ. His research interests in respiratory medicine are primarily in the fields of epidemiology and clinical management. He has over 600 publications, and a Scopus H-index of 77.
Please be informed this meeting will be recorded for an on-demand version to be used after the live meeting for educational purposes. Attendance at AstraZeneca educational meetings is by invitation only and is limited to registered Healthcare Professionals. The company seeks no commitment from external stakeholders to take any action as a result of the invitation or related support. In accordance with the Medicines New Zealand Code of Practice, any costs (for example travel or meals) incurred by a partner/spouse, guest or family member travelling with a healthcare professional must not be paid for or subsidised by the company. AstraZeneca values your health and safety. We choose to use venues and suppliers who have COVID-Safe plans in place. Venues may require you to register on arrival, for contact tracing reasons. All regulations and laws around social distancing, and attendee numbers must be adhered to by all attendees. Please ensure that you have registered, as we may not be able to accommodate you if we have reached these limits. There will be access to hand sanitiser, tissues and face masks should you need/wish to use these. If you are unwell, tested positive for, or had any known symptoms, of COVID #19 in the last 14 days, please ensure you stay home. Your personal information (“Information”) will be collected and used by AstraZeneca Pty Ltd (“AstraZeneca”) to register you for this event, provide you with ongoing information about its products, services and further educational meetings, for follow-up purposes and for any other purpose described in AstraZeneca’s Privacy Policy (see below for link). You can unsubscribe at any time. AstraZeneca may collect your Information from third parties such as travel agents to organise travel arrangements for an event. AstraZeneca may disclose your Information to its related entities or to their service providers (including IT support/service providers). Some of these related entities and service providers may be located overseas including in the US, European Union and Asia Pacific. If you do not provide your Information, AstraZeneca will not be able to register you for this event. Please refer to AstraZeneca’s Privacy Policy at http://www.astrazeneca.com.au/privacy-policy for more information about how your Information is handled and how you may seek to access or correct your Information, or submit a privacy complaint. Our legal notice can be found at http://www.astrazeneca.com.au/legal-notice. Registered user AstraZeneca Limited, PO Box 87453, Meadowbank, Auckland 1742. For Medical Information enquires: Telephone (09) 306 5650 or medinfo.nz@astrazeneca.com. To report an adverse event: Telephone (09) 306 5650 or via https://aereporting.astrazeneca.com. WL127077652. NZ-0912. TAPS DA 1939MC. July 2020